Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 26 announcements

Share price: ₹385.20
Market cap: ₹660.6 Cr
Revenue (annual): ₹46.57 Cr
Net profit (annual): ₹4.62 Cr
P/E (TTM): 143.0×Sector 47.4×
Promoter holding: 72.89%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 2 Annual General Meeting 2 Other Announcement 1 Fund Raise 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

17 Aug 2026 18:06 IST BSE

Capital Structure Change

Aptus Pharma Capital Structure Change

Aptus Pharma approved a preferential issue of 16,02,870 equity shares at Rs. 280 per share, raising approximately Rs. 44.88 Crore. The board also scheduled the 16th AGM.

Value: ₹44.88 Cr

Read the filing ↗

8 Aug 2026 17:27 IST BSE

Capital Structure Change

Aptus Pharma Capital Structure Change

Aptus Pharma approved a preferential issue of 16,10,100 equity shares to various allottees. The company also fixed the Annual General Meeting date for September 14, 2026.

Read the filing ↗